Study guide

8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing

UEMS European Board of Dermatovenereology Diploma Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Eligibility & Examination Regulations

1.1 EBDVD Exam Format, Session Timing & Scoring Rules 1.2 Eligibility Routes, Application Requirements & Re-take Regulations 1.3 UEMS-EBDV Governance, European Training Requirements & Diploma Recognition

2 Chapter 2: Dermatologic Terminology, Lesion Morphology & Skin Biology

2.1 Skin Anatomy, Epidermal Biology & Barrier Function 2.2 Primary & Secondary Lesion Morphology 2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns

3 Chapter 3: Dermatopathology & Diagnostic Procedures

3.1 Biopsy Selection, Processing & Special Staining Techniques 3.2 Major Histopathologic Patterns & Tissue Reaction Types 3.3 Direct & Indirect Immunofluorescence Microscopy

4 Chapter 4: Epidemiology, Photobiology & Occupational Dermatology

4.1 Epidemiological Principles & Cutaneous Disease Burden 4.2 Photobiology & Photoprotection 4.3 Occupational Dermatoses & Contact Sensitisation Surveillance

5 Chapter 5: Papulosquamous, Follicular & Adnexal Disease

5.1 Psoriasis: Variants, Psoriatic Arthritis, Comorbidity & European Management 5.2 Lichen Planus, Lichenoid Eruptions & Other Papulosquamous Disorders 5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis 5.4 Hidradenitis Suppurativa, Hyperhidrosis & Other Sweat Gland Disorders

6 Chapter 6: Hair, Nails & Pigmentary Disorders

6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism 6.2 Nail Disorders, Onychomycosis & Nail Unit Tumours 6.3 Pigmentary Disorders: Vitiligo, Melasma & Other Hypo- and Hyperpigmentation

7 Chapter 7: Drug Reactions, Granulomatous & Deposition Disease and Skin Signs of Systemic Disease

7.1 Cutaneous Adverse Drug Reactions, SCARs & Dermatological Emergencies 7.2 Granulomatous & Deposition Disorders and Panniculitis 7.3 Skin Signs of Systemic Disease, Porphyrias, Nutritional Deficiency & Paraneoplastic Dermatoses

8 Chapter 8: Pruritus, Pregnancy & Geriatric Dermatology, Physical Injury and Mucosal Disease

8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing 8.3 Oral Mucosal, Lip, Genital Mucosal & Perianal (Proctological) Disease

9 Chapter 9: Autoimmune Bullous Diseases

9.1 Pemphigus Group: Pemphigus Vulgaris, Foliaceus & Paraneoplastic Pemphigus 9.2 Pemphigoid Group & Epidermolysis Bullosa Acquisita 9.3 Dermatitis Herpetiformis & Linear IgA Bullous Dermatosis

10 Chapter 10: Eczematous Disorders, Urticaria & Allergology

10.1 Atopic Dermatitis: Pathogenesis, Phenotypes & European Management 10.2 Allergic & Irritant Contact Dermatitis: Pathogenesis, Investigation & Common Allergens 10.3 Urticaria, Angioedema & Cutaneous Mastocytosis 10.4 Immediate-Type Allergy: Diagnostics, Anaphylaxis, Food, Venom & Drug Allergy

11 Chapter 11: Connective Tissue Diseases & Cutaneous Vasculitis

11.1 Cutaneous Lupus Erythematosus Spectrum & Systemic Manifestations 11.2 Dermatomyositis, Systemic Sclerosis & Scleroderma Spectrum 11.3 Cutaneous Vasculitis & Neutrophilic Dermatoses

12 Chapter 12: Paediatric & Genetic Dermatology

12.1 Vascular Anomalies & Benign Neonatal Dermatoses 12.2 Hereditary Ichthyoses & Disorders of Keratinisation 12.3 Genodermatoses, Neurocutaneous Syndromes & Epidermolysis Bullosa

13 Chapter 13: Bacterial, Mycobacterial, Parasitic & Zoonotic Cutaneous Infections

13.1 Bacterial Skin & Soft Tissue Infections 13.2 Mycobacterial Infections: Cutaneous Tuberculosis, Leprosy & Atypical Mycobacteria 13.3 Parasitic Infestations, Arthropod Bites & Cutaneous Leishmaniasis 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections

14 Chapter 14: Viral & Fungal Cutaneous Infections

14.1 Herpesviridae Infections: HSV, VZV & HHV-8 14.2 Poxviruses & Human Papillomavirus Manifestations 14.3 Superficial, Subcutaneous & Deep Mycoses

15 Chapter 15: Sexually Transmitted Infections & Genital Infections

15.1 Syphilis: Pathogenesis, Clinical Stages, Serology & European Management 15.2 Neisseria gonorrhoeae, Chlamydia trachomatis & Genital Ulcer Diseases 15.3 HIV-Related Dermatoses, Partner Notification & Anogenital Lichen Sclerosus 15.4 Non-Gonococcal Urethritis, Mycoplasma genitalium, Trichomoniasis, Vaginal Infections & Balanitis

16 Chapter 16: Sexual Health Services, HIV Prevention & Anogenital Medicine

16.1 STI Epidemiology, Prevention, Services, Sexual History, HIV Testing, ART & PrEP/PEP 16.2 HPV-Related Anogenital Neoplasia, Cervical Screening & Common Gynaecological and Andrological Disorders 16.3 STIs in Pregnancy, Neonates & Children, Contraception, Sexual Health & Psychosexual Problems

17 Chapter 17: Keratinocyte Carcinomas, Precancerous Lesions & Other Skin Tumours

17.1 Actinic Keratoses, Bowen Disease & Field Cancerisation 17.2 Basal Cell Carcinoma: Subtypes, Risk Stratification & Management 17.3 Cutaneous Squamous Cell Carcinoma & Keratoacanthoma 17.4 Benign & Malignant Epidermal, Adnexal, Mesenchymal and Vascular Tumours, Cysts, Histiocytoses & Metastases

18 Chapter 18: Melanocytic Naevi & Melanoma

18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi 18.2 Melanoma Risk Factors, Clinical Presentation & Biopsy Protocol 18.3 Melanoma Histopathology, Breslow Thickness & Staging 18.4 Systemic Therapy for Advanced & Metastatic Melanoma

19 Chapter 19: Dermoscopy, Skin Imaging & Cutaneous Lymphomas

19.1 Dermoscopic Principles, Structures & Algorithmic Approaches 19.2 Dermoscopy of Non-Melanocytic Cutaneous Neoplasms 19.3 Non-Invasive Skin Imaging, Skin Function Measurement, Teledermatology & Skin Cancer Surveillance 19.4 Cutaneous Lymphomas, Merkel Cell Carcinoma & Cutaneous Sarcomas

20 Chapter 20: Dermatopharmacology, Systemic Therapeutics & Prescribing

20.1 Topical Corticosteroids, Calcineurin Inhibitors & Retinoids 20.2 Systemic Immunosuppressive & Biologic Therapies 20.3 Oral Retinoids & Phototherapy Modalities 20.4 Dermatological Prescribing: Anti-Infectives, Antihistamines, Antimalarials, Dapsone, Special Populations & Cutaneous Toxicity of Cancer Therapy

21 Chapter 21: Dermatosurgery, Cryotherapy, Lasers & Aesthetic Procedures

21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications 21.3 Cryosurgery, Electrosurgery & Cutaneous Lasers 21.4 Aesthetic & Corrective Dermatology, Photodynamic Therapy & Dermatological Radiotherapy

22 Chapter 22: Phlebology, Angiology, Psychodermatology & EBDVD Revision

22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema 22.3 Psychodermatology, Delusional Infestation & Factitious Disorders 22.4 EBDVD Revision Strategy & Cross-Topic Review

8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing

Key Takeaways Explain This Topic AI

Wound healing runs through overlapping phases of haemostasis, inflammation (about days 1 to 4), proliferation (about days 4 to 21), and remodelling that lasts up to 1 to 2 years.

A healed scar regains only about 80% of the tensile strength of unwounded skin at best, and about 20% by 3 weeks.

Superficial partial-thickness burns blister, are painful, blanch, and heal in about 2 to 3 weeks, whereas full-thickness burns are leathery, painless, and need excision and grafting.

The Parkland formula gives 4 mL of crystalloid multiplied by body weight in kg and by the percentage of total body surface area burned over 24 hours, with half in the first 8 hours from the time of injury.

Hydrofluoric acid burns need copious irrigation and topical calcium gluconate gel, because fluoride ions bind calcium and can cause deep pain and life-threatening hypocalcaemia.

Last updated: September 2026

  • 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing
  • Normal Wound Healing
  • Phase Timing Main Events
  • Haemostasis Minutes Vasoconstriction, platelet plug, fibrin clot; platelets release PDGF and TGF-beta

Inflammation About days 1–4 Neutrophils clear bacteria, then macrophages remove debris and drive repair with growth factors

Proliferation About days 4–21 Granulation tissue (fibroblasts, new vessels), re-epithelialisation from wound edges and hair follicles, deposition of type III collagen , wound contraction by myofibroblasts

Remodelling (maturation) 3 weeks to 1–2 years Type III collagen replaced by type I collagen , cross-linking, scar paling. Tensile strength is about 20% at 3 weeks and reaches about 80% of normal skin at best

Primary intention: edges brought together (sutured wound), with minimal scarring.

Secondary intention: an open wound fills with granulation tissue and contracts, used for infected wounds or some surgical defects.

Delayed primary (tertiary) intention: closure after a period of open treatment.

Factors that delay healing: ischaemia (arterial disease), venous hypertension, infection and biofilm, diabetes, smoking, malnutrition (protein, vitamin C, zinc), systemic corticosteroids and chemotherapy, previous radiotherapy, pressure, oedema, and advanced age.

Principles of Chronic Wound Care

The TIME framework guides wound bed preparation: T issue (debride non-viable tissue), I nfection or Inflammation (treat and manage biofilm), M oisture balance, and E dge (non-advancing or undermined edges need review, including biopsy to exclude malignancy or pyoderma gangrenosum). Moist wound healing is faster than letting wounds dry out.

  • Dressing Best Use
  • Film Superficial wounds; secondary dressing
  • Hydrocolloid Light-to-moderate exudate; promotes autolytic debridement
  • Hydrogel Dry, sloughy, or necrotic wounds (adds moisture)
  • Alginate / hydrofibre Heavily exuding and bleeding wounds
  • Foam Moderate-to-heavy exudate; cushioning
  • Antimicrobial (silver, iodine, honey, PHMB) Locally infected wounds, for limited periods
  • Negative-pressure wound therapy Large or deep wounds, graft fixation

Hypertrophic scars and keloids are covered in the surgical complications section. In brief, keloids extend beyond the original wound and do not regress, and first-line treatment is intralesional triamcinolone with silicone and pressure.

  • Burns
  • Burn Depth
  • Depth Tissue Involved Appearance Sensation Healing
  • Superficial (epidermal) Epidermis Red, dry, no blisters (sunburn) Painful About 7 days, no scar

Superficial partial-thickness Epidermis and upper dermis Blisters , moist pink base, blanches with brisk refill Very painful About 2–3 weeks, little scarring

Deep partial-thickness Epidermis and deep dermis Mottled red-white, slow or absent refill Reduced Over 3 weeks, with scarring; often needs grafting

Full-thickness Entire dermis White, brown, or black, leathery , no blanching Painless Needs excision and grafting

  • Deeper (fourth-degree) Fat, muscle, bone Charred None Major reconstruction
  • Estimating Burn Area

Rule of nines (adults): head and neck 9%, each arm 9%, front of trunk 18%, back of trunk 18%, each leg 18%, perineum 1%.

Lund and Browder chart: more accurate, and needed for children, whose heads are proportionally larger.

Palm method: the patient's palm with fingers is about 1% of body surface.

Simple erythema is not counted in the total body surface area (TBSA).

Fluid Resuscitation and Referral

Parkland formula: 4 mL × body weight (kg) × %TBSA of crystalloid (for example Hartmann solution) over 24 hours, half in the first 8 hours from the time of the burn , and the rest over the next 16 hours. Adjust to urine output (about 0.5 mL/kg/h in adults). Formal resuscitation is usually needed for burns over about 15% TBSA in adults and 10% in children.

Refer to a burn centre for: large burns (over about 10% TBSA in adults, lower in children and the elderly); any full-thickness burn; burns of the face, hands, feet, genitals, perineum, or major joints ; circumferential burns (risk of compartment syndrome, which may need escharotomy); electrical, chemical, or inhalation injury; burns at the extremes of age; and suspected non-accidental injury.

Chemical and Electrical Burns

Chemical burns: remove contaminated clothing and irrigate with large volumes of water for a long time. Alkalis penetrate deeper than acids.

Hydrofluoric acid: fluoride ions bind calcium and magnesium, causing severe deep pain and possible life-threatening hypocalcaemia and arrhythmia . After irrigation, apply calcium gluconate gel . Deeper injury may need local or intra-arterial calcium gluconate, and calcium and ECG must be monitored.

Electrical burns: small entry and exit wounds can hide extensive deep muscle damage. Check the ECG, creatine kinase, and urine for myoglobin. Lightning can leave fern-like Lichtenberg figures .

Cold Injury

  • Condition Features Management
  • Frostnip Reversible pallor and numbness Rewarm

Frostbite Tissue freezing; superficial (clear blisters) or deep (haemorrhagic blisters, then black eschar) Rapid rewarming in a water bath at about 37–39 °C , analgesia, avoid refreezing; iloprost or thrombolysis in specialist centres for deep injury; wait for demarcation before amputation

Non-freezing cold injury (trench or immersion foot) Cold, wet exposure over days; painful, swollen feet Warm and dry; long-term neuropathic pain

Chilblains (perniosis) Itchy or painful red-violet papules on fingers and toes in cold, damp weather Keep warm, stop smoking, nifedipine; exclude chilblain lupus and cryoglobulins in persistent cases

Cold panniculitis and cold urticaria are covered in their own sections.

Heat Injury

Erythema ab igne: reticulate red-brown pigmentation from repeated exposure to heat below the burn threshold (hot water bottles, heating pads, laptops, heaters). It may hint at underlying chronic pain, and long-standing lesions carry a small risk of squamous cell carcinoma.

Miliaria (heat rash) is covered in the sweat gland section.

Radiation Injury

Acute radiation dermatitis is graded from 1 to 4 (common terminology criteria): faint erythema or dry desquamation; moist desquamation mostly in skin folds; confluent moist desquamation outside folds; and skin necrosis or ulceration. Management includes gentle washing, emollients, mild topical steroids for inflamed skin, and non-adherent dressings for moist areas.

Chronic radiation dermatitis: poikiloderma (atrophy, telangiectasia, pigment change), fibrosis, hair loss, and late ulcers that heal poorly.

Late malignancy: basal cell carcinoma, squamous cell carcinoma, and angiosarcoma (for example of the breast after breast-conserving radiotherapy).

Radiation recall: inflammation limited to a previously irradiated field after certain drugs (for example some chemotherapy agents).

Fluoroscopy injury: delayed erythema, ulceration, or sclerosis on the back after long interventional procedures.

Mechanical Injury

Friction blisters: intraepidermal splits from repeated shear, for example in runners and soldiers.

Callus and corns: thickened skin from pressure. A hard corn (heloma durum) sits over bony prominences, and a soft corn (heloma molle) lies between toes. Paring separates a corn (central translucent core) from a plantar wart (pinpoint bleeding from capillaries, interrupted skin lines).

Black heel (talon noir): black dots of intracorneal blood on the heels in athletes, a mimic of melanoma. It pares away.

Pressure injury: see the geriatric dermatology section.